Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept

BACKGROUND: In de novo kidney transplant recipients (KTR) treatment with belatacept has been established as a comparable option as maintenance immunosuppression, preferably as a strategy to convert from calcineurin inhibitor (CNI)- to belatacept-based immunosuppression. Switch to belatacept demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Mira, Bachmann, Friederike, Wu, Kaiyin, Lachmann, Nils, Schmidt, Danilo, Brakemeier, Susanne, Duerr, Michael, Kahl, Andreas, Eckardt, Kai-Uwe, Budde, Klemens, Nickel, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439694/
https://www.ncbi.nlm.nih.gov/pubmed/32819287
http://dx.doi.org/10.1186/s12882-020-01992-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439694/
https://www.ncbi.nlm.nih.gov/pubmed/32819287
http://dx.doi.org/10.1186/s12882-020-01992-6

Ejemplares similares